Results 151 to 160 of about 55,360 (258)

Significance of Early Proton Beam Therapy Initiation in Achieving Complete Response in Pediatric Medulloblastoma: A Retrospective Study. [PDF]

Cancer Med
Shen Z, Hou Z, Han W, Zhang Y, Zhang W, Wu S, Liang J, Jiang C, Wang Z, Wang W, Zhang S, Sakurai H, Shimizu Qingshui Xiangxing S.   +12 more
europepmc   +1 more source

Recent Advances in the Laser‐Based Fabrication and Applications of High‐Entropy Alloy Nanoparticles

MetalMat, Volume 3, Issue 2, June 2026.
This review presents recent advances in the laser‐based fabrication of high‐entropy alloy nanoparticles, focusing on scalable, environmentally friendly, and compositionally tunable synthesis methods. It highlights the critical influence of laser parameters on nanoparticle size, phase, and morphology, enabling tailored properties for applications in ...
Bibek Kumar Singh, Rajesh Rawat, Archana Tiwari, Venugopal Rao Soma, Ajay Tripathi   +4 more
wiley   +1 more source

Estimating proton beam therapy utilization and Investment in Thailand. [PDF]

Front Public Health
Chitapanarux I, Tharavichitkul E, Prayongrat A, Sripan P, Zubizarreta E, Anacak Y, Siraprapasiri P, Tungkasamit T, Changmanee C.   +8 more
europepmc   +1 more source

The Dual Role of Autophagy in Cancer: Mechanisms and Therapeutic Strategies

MedComm – Oncology, Volume 5, Issue 2, June 2026.
Autophagy is a conserved cellular process degrading dysfunctional organelles and protein aggregates to maintain cell homeostasis, and it exhibits context‐dependent duality in cancer. Autophagy functions as a critical tumor‐suppressive mechanism by preventing DNA damage and mutation during tumor initiation.
Xiang‐Zheng Gao, Yuheng Qin, Haoyu Wan, Guang Lu, Han‐Ming Shen   +4 more
wiley   +1 more source

Case Report: Proton beam therapy - friend or foe for patients with <i>IDH</i>-mutated WHO grade 2 and 3 gliomas? [PDF]

Front Oncol
Heggebø LC, Fjæra LF, Garrote FLB, Borgen IMH, Blakstad H, Hellebust TP, Saxhaug C, Knutstad K, Rylander H, Henry T, Gustafsson M, Werlenius K, Blomstrand M, Brandal P.   +13 more
europepmc   +1 more source

Cell survival comparison of proton, helium, and carbon ion interlaced minibeams in water phantom simulations

Medical Physics, Volume 53, Issue 6, June 2026.
Abstract Background Radiotherapy is a key in cancer treatment, with particle therapy providing better tumor targeting and sparing healthy tissues. Particle Minibeam Radiotherapy (PMBT) integrates the advantages of spatial fractionation into particle radiotherapy by employing submillimeter‐sized beams, thus improving the therapeutic ratio by reducing ...
Aikaterini Rousseti, Günther Dollinger, Judith Reindl   +2 more
wiley   +1 more source

Correction: Range quality assurance measurements for clinical and FLASH proton beam therapy using the quality assurance range calorimeter. [PDF]

Front Oncol
Shaikh S, Escribano-Rodriguez S, Radogna R, Saakyan R, Manger S, Henthorn N, Warmenhoven JW, Taylor M, Jolly S.   +8 more
europepmc   +1 more source

Toward universal dose prediction: A multi‐scale, multi‐objective framework for sequential boost radiotherapy

Medical Physics, Volume 53, Issue 6, June 2026.
Abstract Background Sequential boost radiotherapy (RT) poses a challenge in allocating dose across multiple plans while protecting organs at risk (OARs). Clinicians must decide whether OAR sparing should occur primarily in the initial plan, the boost plan(s), or all plans, resulting in a time‐intensive, iterative optimization process.
Austen Matthew Maniscalco, Xinran Zhong, Sean Domal, Yu‐Chen Lin, David Sher, Mu‐Han Lin, Steve Jiang, Dan Nguyen   +7 more
wiley   +1 more source

Prognostic significance of the neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma treated with proton beam therapy. [PDF]

Radiat Oncol J
Makita K, Hojo H, Hirata H, Dey T, Nakamura M, Fujisawa T, Kotani D, Wakabayashi M, Oyoshi H, Tomizawa K, Zhou Y, Koike Y, Uchida G, Mishima S, Kojima T, Zenda S.   +15 more
europepmc   +1 more source

Fear of Progression in Pediatric Cancer Patients and Their Parents: Trajectories, Prevalence, and Correlates Across Acute Treatment and Follow‐Up Care

Psycho-Oncology, Volume 35, Issue 6, June 2026.
ABSTRACT Purpose Fear of progression (FoP) represents a significant psychological burden for pediatric cancer patients and their parents. This study investigates FoP levels across acute treatment (AcT) and follow‐up care (FuC) and examines trajectories over time, associated sociodemographic factors, and parent‐child associations.
Jessy Herrmann, Kristina Herzog, Julia Martini, Anja Santel, Leonard Konstantin Kulisch, Jörn‐Sven Kühl, Florian Schepper   +6 more
wiley   +1 more source